Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM SystemPRNewsWire • 12/02/21
Dow Jones Newswires: Nevro to pay Boston Scientific $20 million in patent infringement caseMarket Watch • 11/01/21
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/27/21
Boston Scientific stock gains after profit tops expectations, while sales came up a bit shortMarket Watch • 10/27/21
Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal StentsPRNewsWire • 10/06/21
Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis DealBenzinga • 10/06/21